Igbo
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Aha: Onyeisi Dọkịta
Ọnọdụ: Onyeisi Ngalaba
Profaịlụ Onwe: Onyeisi Dọkịta, Prọfesọ, Ph.D. Onye Nlekọta, ugbu a bụ Onyeisi Ngalaba Hematology nke Ụlọ Ọgwụ Peking Tongren. Ọ gụsịrị akwụkwọ na Peking Union Medical College na 2010, gụrụ akwụkwọ na Clinical Medicine na usoro afọ asatọ, wee nweta akara ugo mmụta Doctor of Medicine. Ọ nọwo na-enyocha ma na-agwọ ọrịa hematologic tumors (lymphoma, multiple myeloma, wdg) ruo ihe karịrị afọ 10, ma nwee ahụmịhe ahụike bara ụba na agụmakwụkwọ dị elu na nchọpụta na ọgwụgwọ nke ụdị lymphomas na myelomas dị iche iche, ma bụrụ ọkachamara na immunotherapy a na-elekwasị anya, chemotherapy, ọgwụgwọ mkpụrụ ndụ CAR-T, transplant mkpụrụ ndụ hematopoietic, ma na-eduga mmepe nke nchọpụta na ọgwụgwọ multidisciplinary (MDT). Isi ihe ọ na-achọ bụ nchọpụta immunotherapy na usoro mgbochi ọgwụ nke lymphoma, ọ chịkwara ọtụtụ National Natural Science Foundation nke China. O bipụtala ihe karịrị akwụkwọ ọkachamara iri anọ, gụnyere ihe karịrị akwụkwọ iri atọ e depụtara na SCI, nke e bipụtara na Lancet Hematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, na akwụkwọ akụkọ na akwụkwọ akụkọ ndị ọzọ. O bipụtala na Lancet Hematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, na Leukemia & Lymphoma. Ọ bụ onye nchịkọta akụkọ nke Standard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, na Medical Oncology. E nyere ya onyinye "Nkwanye ugwu maka ndụ-2017 Glory to Healers-Youth Innovation Award", onyinye "Tongren Elite" na 2020, onyinye "Tongren Hospital Outstanding Young Talent" na 2020, na onyinye mbụ "Tongren Hospital Outstanding Young Talent" na 2020. Tongren Hospital Outstanding Young Talent" na 2020, '35 Young Oncologists Under 35 with the Most Potential in China'. Agụmakwụkwọ Mmekọ: Onye ntorobịa nke ngalaba Hematology nke China Medical Association; Onye otu kwụ ọtọ nke Lymphoma Immunotherapy Committee nke Beijing Cancer Prevention and Control Society; Onye otu kwụ ọtọ nke Myeloma Committee nke China Medical Education Association; Ọkachamara nke National Natural Science Foundation nke China. Ọ bụ onye nchịkọta akụkọ nke Aging Pathobiology and Therapeutics, onye otu nchịkọta akụkọ nke Chinese Journal of Cancer Prevention and Control, onye otu nchịkọta akụkọ na-eto eto nke Concord Medical Journal, na onye nyocha nke Journal of Hematology & Oncology and Cancer Biology & Medicine.

Wang Liang